Efficacy and safety of acupuncture treatment for fatigue after COVID-19 infection: a pilot randomized sham-controlled trial

Kyung Hee University0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年3月4日

适应症

试验速览

暂无简介。

•1) Those who have been diagnosed with COVID-19 and quarantined (and cured) at least one month ago
•2) Adults between 20 and 65 years of age
•3) Those who are experiencing fatigue that has persisted for more than 4 weeks after being cured of COVID-19, and whose symptom intensity of 4 or higher on the 0-10 numeric rating scale
•4) Those who voluntarilly agree to participate in the study through a written consent form after being clearly explained of the purpose and characteristics of this clinical study

•1) Those who have a history of diseases(cancer, anemia, hypothyroidism or psychiatric disease such as depression) or surgical operation that can cause sequelae before the infection of COVID-19
•2) Those who have a fear of acupuncture treatment
•3) Women who are pregnant, may become pregnant or are lactating
•4) Those who are judged that it is difficult to comply with this treatment protocol, visiting the hospital, or filing in a questionnaire, etc.
•5) Those who are participating in another clinical study
•6) Subjects who are judged to be inappropriate for the clinical study by the researchers

发起方